AKT1 and relapsing-remitting multiple sclerosis: The blockade of PD-1, however, promotes the proliferation of lymphocytes via upregulating p-AKT during the acute phase of relapsing-remitting multiple sclerosis (RRMS) (Trabattoni et al., 2009).